Insider buying
~$195K33K sh @ $5.89
Traded Nov 16 · filed 2 days later
Since the trade −15.3% · S&P 500 −6.8% · to Nov 20
Bought 18% below the 52-week high, RSI 53, 29% above its 200-day average, 86 points ahead of the S&P 500 over 3 months
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 2 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
Traded Nov 16 · filed 2 days later
Since the trade −15.3% · S&P 500 −6.8% · to Nov 20
Bought 18% below the 52-week high, RSI 53, 29% above its 200-day average, 86 points ahead of the S&P 500 over 3 months
A major shareholder of Bolt Biotherapeutics paid $195K out of pocket for Bolt Biotherapeutics shares. Shares held went up 7% with this purchase.
Lately at Bolt Biotherapeutics: the stock rose 50% in one session on Oct 23 around a company release; it reported its results on Nov 12; the stock is up 19% in 30 days.
Insider buying
Traded Nov 18 · filed the same day
Since the trade −19.4% · S&P 500 −5.5% · to Nov 20
Bought 70% below the 52-week high, RSI 40, 27% under its 200-day average
A Xbp Global director paid $57K out of pocket for Xbp Global shares. It was the first purchase in 6 months. Shares held went up 50% with this purchase.
Lately at Xbp Global Holdings: the stock fell 14% in one session on Nov 17 around a company release; it reported its results on Nov 16; the stock is down 27% in 30 days.
Insider selling
Traded Nov 18 · filed the same day
A major shareholder of Arista Networks told the SEC about a plan to sell $58.2M of Arista Networks shares around Nov 18, 2026. The shares were not acquired as compensation. That is a tiny part of all Arista Networks shares.
Lately at Arista Networks: the stock fell 12% in one session on Nov 20 with press coverage; it reported its results on Nov 3; the stock is down 9% in 30 days.
Insider selling
Traded Nov 18 · filed the same day
A H World insider told the SEC about a plan to sell $46.8M of H World shares around Nov 18, 2026. The shares were not acquired as compensation. That is 0.3% of all H World shares.
Lately at H World Group: the stock is up 12% in 30 days.
Insider selling
Traded Nov 18 · filed the same day
A major shareholder of Primo Brands told the SEC about a plan to sell $615M of Primo Brands shares around Nov 18, 2026. The shares were not acquired as compensation. That is 7.3% of all Primo Brands shares.
Lately at Primo Brands: it reported its results on Nov 5; the stock is up 16% in 30 days; insiders made no purchase ($10K+) and 3 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −3.1% · S&P 500 −5.8% · to Nov 20
Bought 23% below the 52-week high, RSI 49, 4% above its 200-day average
The CEO of Biglari paid $173K out of pocket for Biglari shares.
Lately at Biglari: the stock rose 16% in one session on Nov 9 with press coverage; it reported its results on Nov 6; the stock is down 14% in 30 days.
Insider buying
First insider buy since Sep 2025Traded Nov 16 · filed 2 days later
Since the trade −5.1% · S&P 500 −6.8% · to Nov 20
Bought within 4% of the 52-week low, RSI 42, 14% under its 200-day average
A Slr Investment director paid $115K out of pocket for Slr Investment shares. It was the first purchase in 20 months.
Lately at Slr Investment: it reported its results on Nov 3; the stock is 33% below its 12-month high; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since Mar 2025Traded Nov 16 · filed 2 days later
Since the trade +17.4% · S&P 500 −6.8% · to Nov 20
Bought at the 52-week low, RSI 34, 50% under its 200-day average, 37 points behind the S&P 500 over 3 months
A Stereotaxis director paid $11K out of pocket for Stereotaxis shares. 2 other people at Stereotaxis bought some too, in the same month. It was the first purchase in 12 months.
Lately at Stereotaxis: it signed an important agreement on Nov 10; the stock is down 5% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −0.8% · S&P 500 −5.8% · to Nov 20
Bought 34% below the 52-week high, RSI 57, 14% under its 200-day average
The CEO of Crescent Capital Bdc paid $50K out of pocket for Crescent Capital Bdc shares. It was the first purchase in 6 months. Shares held went up 10% with this purchase.
Lately at Crescent Capital Bdc: the stock rose 12% in one session on Nov 10 around a company release; it reported its results on Nov 9; the stock is up 15% in 30 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −4.5% · S&P 500 −5.8% · to Nov 20
Bought 38% below the 52-week high, RSI 25, 18% above its 200-day average
The CEO of Atlassian paid $141K out of pocket for Atlassian shares.
Lately at Atlassian: the stock fell 16% in one session on Nov 6 around a company release; it changed a top executive or board member on Nov 5; the stock is down 40% in 30 days.
Insider buying
4 insiders in a week, 3rd time since 2007Traded Nov 18 · filed the same day
Since the trade −4.3% · S&P 500 −5.5% · to Nov 20
Bought at the 52-week low, RSI 21, 55% under its 200-day average, 50 points behind the S&P 500 over 3 months
Altimmune's Principal Accounting Officer paid $14K out of pocket for Altimmune shares. 3 other people at Altimmune bought some too, in the same month. It was the first purchase in over a year.
Lately at Altimmune: it reported its results on Nov 12; the stock is down 40% in 30 days; insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Traded Nov 16, 2026 · largest single transaction ~$93K
Lately at Freightcar America: the stock rose 15% in one session on Nov 10 around a company release; it reported its results on Nov 9; the stock is 71% below its 12-month high.
Nov 16, 2026~$92K · 20K sh @ $4.62
DetailsOfficial recordNov 16, 2026~$93K · 20K sh @ $4.65
DetailsOfficial recordTraded Nov 16, 2026 · largest single transaction ~$391K
Lately at Geopark: the stock is down 25% in 30 days; insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$391K · 43K sh @ $9.10
DetailsOfficial recordNov 16, 2026~$391K · 43K sh @ $9.10
DetailsOfficial recordNov 16, 2026~$391K · 43K sh @ $9.10
DetailsOfficial recordNov 16, 2026~$391K · 43K sh @ $9.10
DetailsOfficial recordInsider selling
Traded Nov 18 · filed the same day
A Snowflake officer told the SEC about a plan to sell $13.8M of Snowflake shares around Nov 18, 2026. The shares were not acquired as compensation. That is a tiny part of all Snowflake shares.
Lately at Snowflake: the stock is down 21% in 30 days; members of Congress disclosed 3 purchases and 1 sale in 90 days.
Insider buying
3 insiders in a week, 3rd time since 2022Traded Nov 17 · filed 1 day later
Since the trade +12.2% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 28, 44% under its 200-day average, 43 points behind the S&P 500 over 3 months
An Opal Fuels director paid $12K out of pocket for Opal Fuels shares. 3 other people at Opal Fuels bought some too, in the same month.
Lately at Opal Fuels: it reported its results on Nov 9; the stock is down 16% in 30 days; insiders made 11 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since May 2024Traded Nov 17 · filed 1 day later
Since the trade +2.1% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 28, 21% under its 200-day average, 14 points behind the S&P 500 over 3 months
The CEO of National Health Investors paid $91K out of pocket for National Health Investors shares.
Lately at National Health Investors, Inc.: it changed a top executive or board member on Nov 13; the stock is down 6% in 30 days.